A case of a telangiectatic erythema appearing after implantation of a pacemaker is described. The eruption cleared completely after removal of the battery.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000249900 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Tranexamic Acid for the Treatment of Hyperpigmentation and Telangiectatic Disorders Other Than Melasma: An Update.
Clin Cosmet Investig Dermatol
September 2024
The Institute of Dermatology and Venereology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.
Article Synopsis
- - Tranexamic acid (TXA) is primarily an antifibrinolytic agent used to control bleeding in trauma and surgeries, and it also helps prevent bleeding in hemophilia patients.
- - Recent studies suggest TXA has additional benefits like reducing pigmentation, inflammation, and promoting skin recovery, leading to its exploration as a treatment for various skin issues.
- - The review focuses on TXA's effectiveness for conditions like post-inflammatory hyperpigmentation and rosacea, advocating for its potential use beyond melasma as a safer, cost-effective treatment option.
Generalized cutis marmorata telangiectatica congenita or neonatal lupus? A case report and literature review.
Clin Case Rep
May 2024
Department of Dermatology, School of Medicine Molecular Dermatology Research Center, Shiraz University of Medical Science Shiraz Iran.
Article Synopsis
- Cutis marmorata telangiectatica congenita (CMTC) is characterized by a marbled appearance of the skin and can be linked to various complications.
- A thorough evaluation by multiple medical specialties is essential for effective management of CMTC.
- Current treatment options are not well-established due to limited evidence, highlighting the need for more research and comprehensive care approaches.
A case of Bloom syndrome manifesting with therapy-related myelodysplastic syndromes harboring a novel BLM gene variant.
Int J Hematol
May 2024
Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Article Synopsis
- Bloom syndrome (BS) is a rare genetic disease caused by changes in the BLM gene, which helps keep our genes stable and healthy.
- People with BS have unique facial features, longer limbs, and skin problems like sensitivity to sunlight.
- A 34-year-old woman with BS had a history of different cancers and passed away at 35; genetic tests showed she had two different harmful changes in the BLM gene.
Challenges in the Diagnosis of Cutaneous Mastocytosis.
Diagnostics (Basel)
January 2024
St John's Institute of Dermatology, Guy's Hospital, London SE1 9RT, UK.
Background: Mastocytosis is characterized by an accumulation of clonal mast cells (MCs) in tissues such as the skin. Skin lesions in mastocytosis may be clinically subtle or heterogeneous, and giving the correct diagnosis can be difficult.
Methods: This study compiles personal experiences together with relevant literature, discussing possible obstacles encountered in diagnosing skin involvement in mastocytosis and cutaneous mastocytosis (CM).
Bloom syndrome (BS) is a rare autosomal recessive inherited disorder. Patients with BS have photosensitivity, telangiectatic facial erythema, and stunted growth. They usually have mild microcephaly, and distinctive facial features such as a narrow, slender face, micrognathism, and a prominent nose.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!